Mehdi Mirsaeidi. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antitubercular Agents/administration & dosageHumansIsoniazid/administration & dosageMaleRifampin/analogs & derivativesTuberculosis/prevention & control
Substances: See more » Antitubercular AgentsIsoniazidRifampin
Year: 2012 PMID: 22494128 DOI: 10.1056/NEJMc1200489
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245